These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1989149)

  • 1. Increased cyclosporine levels as a result of simultaneous fluconazole and cyclosporine therapy in renal transplant recipients: a double-blind, randomized pharmacokinetic and safety study.
    Canafax DM; Graves NM; Hilligoss DM; Carleton BC; Gardner MJ; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1041-2. PubMed ID: 1989149
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
    Sridhar N; Schroeder TJ; Pesce AJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group.
    Massari PU; Grosso S; de Boccardo G; Vásquez MC; Schiavelli RO; Sabbatiello RR; Casadei DH; Rial MC; Jost LJ; Túrin MD; Agost Carreño C A; Maggiora EC; Gadea MM
    Transplant Proc; 1996 Dec; 28(6):3365-7. PubMed ID: 8962310
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.
    Vanrenterghem Y; Waer M; De Keyser P; Roels L; Michielsen P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):615-7. PubMed ID: 3291296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and safety of vardenafil for kidney transplant recipients with erectile dysfunction].
    Yang J; Ju W; Zeng FQ; Xiao YJ; Zhang XP; Xiao CG
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):911-3. PubMed ID: 19157102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Abouna GM; Kumar SM; White AG; Samhan M; Kalawi M; al-Sabawi N
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1009-10. PubMed ID: 1989140
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 8. Longterm cyclosporine therapy in rheumatoid arthritis.
    van Rijthoven AW; Dijkmans BA; Goei Thè HS; Boers M; Cats A
    J Rheumatol; 1991 Jan; 18(1):19-23. PubMed ID: 2023194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.
    Niese D
    Transplant Proc; 1995 Apr; 27(2):1849-56. PubMed ID: 7725531
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine A capsules: bioavailability and clinical acceptance study in renal transplant patients.
    Zehnder C; Beveridge T; Nüesch E; Abisch A; Thiel G
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):641-3. PubMed ID: 3284114
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
    Olivari MT; Antolick A; Ring WS
    J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of steroids versus no steroids in stable cyclosporine-treated renal graft recipients.
    Gulanikar AC; Belitsky P; MacDonald AS; Cohen A; Bitter-Suermann H
    Transplant Proc; 1991 Feb; 23(1 Pt 2):990-1. PubMed ID: 1989355
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
    Barone G; Bunke CM; Choc MG; Hricik DE; Jin JH; Klein JB; Marsh CL; Min DI; Pescovitz MD; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL
    Transplant Proc; 1996 Aug; 28(4):2183-6. PubMed ID: 8769194
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
    Levy G; Schmidli H; Punch J; Tuttle-Newhall E; Mayer D; Neuhaus P; Samuel D; Nashan B; Klempnauer J; Langnas A; Calmus Y; Rogiers X; Abecassis M; Freeman R; Sloof M; Roberts J; Fischer L
    Liver Transpl; 2006 Nov; 12(11):1640-8. PubMed ID: 16598777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
    [No Abstract]   [Full Text] [Related]  

  • 17. Is cyclosporine indicated in HLA-identical renal transplant recipients?
    Sumrani N; Delaney V; Ding Z; Davis R; Butt K; Hong J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
    [No Abstract]   [Full Text] [Related]  

  • 18. Absorption profiles of renal allograft recipients receiving oral doses of cyclosporine: a pharmacokinetic study.
    Phillips TM; Karmi SA; Frantz SC; Henriques HF
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):457-61. PubMed ID: 3284090
    [No Abstract]   [Full Text] [Related]  

  • 19. Supplementation with anti-oxidants Vitamin C and E decreases cyclosporine A trough-levels in renal transplant recipients.
    de Vries AP; Oterdoom LH; Gans RO; Bakker SJ
    Nephrol Dial Transplant; 2006 Jan; 21(1):231-2. PubMed ID: 16115840
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.